Peptide Laboratory Practice
Peptide Adsorption to Glass vs Plastic Explained
Prevent peptide loss by testing glass, polypropylene, low-binding tubes, filters, concentration, and transfers instead of assuming one surface fits all.
The peptide did not always degrade. Sometimes it is on the tube wall. Surface adsorption can remove a large fraction of a dilute peptide stock while the remaining solution stays clear and the LC-MS identity still looks perfect. The result is a high-purity chromatogram with low and variable recovery.
There is no universal rule that polypropylene is better than glass. Published comparative work across endocrine peptides found that the best surface depended on the analyte. Polystyrene produced poor recovery for several peptides, while other materials performed differently for ghrelin, insulin, and nesfatin-1. Sequence, net charge, hydrophobicity, modification, concentration, buffer, and contact time all matter.
Lipidated peptides and hydrophobic fragments can bind strongly to interfaces. Highly cationic antimicrobial peptides interact with charged surfaces. Very low concentrations increase the surface-area-to-mass problem. Every transfer creates another opportunity for loss.
Diagnose adsorption before changing the chemistry
Prepare the same peptide at several concentrations in candidate containers. Analyze immediately and after the intended hold time. Include mass recovery, not only area purity. If percent recovery improves as concentration rises, nonspecific binding is likely. A degradation process may also depend on concentration, so inspect impurity growth and total signal together.
Run a transfer study: prepare in one tube, move through the planned pipette tips, filter, autosampler vial, and insert, then compare with a no-transfer control. Test each step separately. Laboratories often spend weeks changing LC gradients when the largest loss occurs in a syringe filter.
Pre-rinsing, siliconized surfaces, low-binding plastics, carrier protein, surfactant, or an organic modifier may improve recovery, but each intervention changes the method. BSA can reduce adsorption in some biological assays, yet it is unsuitable for many MS workflows and can introduce contamination. Select a compatible approach and validate it.
Filters are surfaces too
Membrane material, pore size, housing, dead volume, and peptide concentration affect recovery. “Low protein binding” is not a peptide-specific guarantee. Compare filtered and unfiltered samples using a validated particulate-control strategy. If filtration is necessary, perform spike recovery across the working range and account for the initial volume retained by the device.
Do not discard the filter during an investigation. Rinsing or extracting it can show whether the missing analyte is retained. The result may distinguish adsorption from precipitation, although extraction efficiency must be understood.
Autosampler components deserve the same scrutiny. Glass inserts, polypropylene vials, cap septa, needle paths, and tubing can contribute. A declining response across replicate injections may reflect depletion at the interface or sample instability. Bracket with a fresh preparation.
Recovery study checklist
- Exact container resin or glass type, manufacturer, lot, surface treatment, and fill volume.
- Peptide sequence, modification, salt form, buffer, pH, concentration, and contact time.
- Independent preparations in glass, standard plastic, and a suitable low-binding option.
- Transfer, tip, filter, insert, and autosampler tests performed one variable at a time.
- Absolute recovery, impurity profile, replicate precision, and visible/subvisible observations.
- Acceptance criteria tied to the experiment’s required concentration accuracy.
One common error is comparing containers with different fill volumes. The surface-to-volume ratio changes, so material and geometry are confounded. Another is using a high-concentration stock to approve a vessel, then assuming the same recovery at picomolar assay levels.
Solubility and adsorption can overlap
A peptide may first form small aggregates and then deposit on the wall. Conversely, adsorption can nucleate further association. Examine concentration dependence, gentle mixing, particle data, and recovery after a compatible rinse. Do not force the sample clear with extreme pH before documenting the initial loss.
Adsorption can also make stability look better. If an oxidized impurity binds more strongly than the parent, the solution chromatogram understates degradation. Mass balance and surface extraction may be required during a serious investigation.
Procurement teams should ask suppliers what container and concentration were used for the COA. A method demonstrated at 1 mg/mL in one vial may not transfer to a nanomolar bioassay or a different autosampler plate.
Keep validated low-binding consumables under change control. “Polypropylene” covers formulations and surface treatments that can behave differently. Requalify after a supplier or catalog change.
Pipetting and plate-layout effects
Low recovery may start in the pipette tip. Pre-wetting can improve precision for some solutions, while repeated aspiration increases interface exposure for others. Test the exact tip, volume range, mixing cycles, and dwell time used in the assay. Positive-displacement systems may help with viscous or organic-rich preparations, but they also need recovery qualification.
In microplates, edge wells can behave differently because evaporation changes concentration and surface contact. Randomize or control plate position, seal consistently, and include recovery controls across the plate. A standard curve placed only in center wells may not reveal loss in edge samples.
Carryover can mimic adsorption recovery. A peptide lost from one injection may appear in the next strong wash or sample. Run blanks after high standards and inspect the entire gradient. When switching vessel type changes both recovery and carryover, investigate the autosampler path rather than crediting the vial alone.
For quantitative bioanalysis, adsorption during sample collection and extraction compounds the problem. Matrix proteins may reduce wall binding while creating ion suppression. Validate recovery at low, middle, and high concentrations in the actual matrix, not only in neat buffer. A stable isotope internal standard corrects some processing variability only if it is added early and behaves like the analyte.
Record unsuccessful materials as well as the selected one. Future teams otherwise repeat the same comparison after a consumable change. The laboratory notebook should capture manufacturer, part number, resin, treatment, lot, and measured recovery.
Peptides Archive can help design an RUO recovery comparison or interpret unexplained low assay results. This is laboratory handling guidance, not formulation for administration or human use.
Primary records and verification routes
Use the primary paper, current regulator record, or lot-linked analytical file for the claim it supports. A search result is a route to evidence, not evidence itself.